| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,921,000 | 3,262,000 | 3,696,000 | 2,561,000 | | Cost of Revenue | 2,743,000 | 1,743,000 | 1,888,000 | 1,540,000 | | | Gross Profit | 1,178,000 | 1,519,000 | 1,808,000 | 1,021,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,000 | 664,000 | 633,000 | 651,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 207,000 | 195,000 | 210,000 | 193,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 927,000 | 660,000 | 965,000 | 177,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (44,000) | (140,000) | (31,000) | 17,000 | | Earnings Before Interest And Taxes | 893,000 | 529,000 | 958,000 | 195,000 | | Interest Expense | 145,000 | 146,000 | 148,000 | 147,000 | | Income Before Tax | 748,000 | 383,000 | 810,000 | 48,000 | | Income Tax Expense | 304,000 | 146,000 | 332,000 | 214,000 | | Minority Interest |
-
| (1,000) | (3,000) | 1,000 | | | | Net Income From Continuing Ops | 444,000 | 237,000 | 478,000 | (166,000) | | | Non-recurring Events | | Discontinued Operations |
-
| (3,000) | 178,000 | 16,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 444,000 | 234,000 | 656,000 | (150,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $444,000 | $234,000 | $656,000 | ($150,000) |
|
0.45% Nasdaq 
0.20%
Income Statement
